skip to main content

H.R. 5122 (114th): To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models.


The text of the bill below is as of Apr 29, 2016 (Introduced). The bill was not enacted into law.


I

114th CONGRESS

2d Session

H. R. 5122

IN THE HOUSE OF REPRESENTATIVES

April 29, 2016

(for himself, Mr. Dold, Mr. Boustany, Mr. Tom Price of Georgia, and Mr. Shimkus) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned

A BILL

To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models.

1.

Prohibition of further action on proposed rule regarding testing of Medicare part B prescription drug models

The Secretary of Health and Human Services may not take any action to finalize, implement, or enforce the proposed rule entitled Medicare Program; Part B Drug Payment Model (81 Fed. Reg. 13230 (March 11, 2016)).